Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-347-8 | CAS number: 6484-52-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The acute oral and dermal toxicity (LD50) is >2000 and >5000 mg/kg bw, respectively for ammonium nitrate. The acute inhalation toxicity is not tested, the vapour pressure is negligilbe and the particle size of ammonium nitrate shows no inhalable fraction.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Sept-Oct. 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Study performed before GLP was in place and comparable to guidelines.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- other: acute oral median lethal dose
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: methylcellulose and Tween 80
- Doses:
- Range finder: 50, 250, 1250, 5000 mg/kg
Definitive: 2000, 2380, 2830, 3360 mg/kg - No. of animals per sex per dose:
- Range finder: 2
Definitive: 5 - Control animals:
- not specified
- Preliminary study:
- The mortalities indicated an LD50 in the range 1250-5000 mg/kg.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 950 mg/kg bw
- Mortality:
- Mortality occurred at 3360 (7/10), 2830 (3/10), 2380 (4/10) mg/kg and also 1 animal in 2000 mg/kg.
- Clinical signs:
- other: Prostration, lethargy and deep rapid breathing were the main clinical signs. All surviving animals appeared normal at day 1, except at the highest dose tested animals appeared normal at day 2.
- Gross pathology:
- For animals that died, congested lungs was the major pathological finding.
- Interpretation of results:
- Category 5 based on GHS criteria
- Remarks:
- Not classified according to Regulation (EC) No 1272/2008
- Conclusions:
- LD50 = 2950 mg/kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study has klimisch code 2.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Value:
- mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The study has klimisch code 1.
Additional information
Acute oral toxicity:
Based on a reliable prior to GLP performed acute oral study in rats with ammonium nitrate the LD50 is considered to be 2950 mg/kg bw. Mortality occurred at 3360 (7/10), 2830 (3/10), 2380 (4/10) mg/kg and also 1 animal in 2000 mg/kg. Prostration, lethargy and deep rapid breathing were the main clinical signs. All surviving animals appeared normal at day 1, except at the highest dose tested animals appeared normal at day 2. All surviving animals showed body weight gains. For animals that died, congested lungs was the major pathological finding.
All oral acute studies with reliability 4 reported LD50 values above 2000 mg/kg bw. Therefore the oral LD50 for ammonium nitrate is considered to be >2000 mg/kg bw.
Acute dermal toxicity:
Based on a reliable, OECD 402 acute dermal toxicity study in rats with ammonium nitrate itself, the LD50 is shown to be >5000 mg/kg bw. No effects on bodyweight, clinical signs, gross pathology and mortality have been observed.
Acute inhalation toxicity:
No reliable acute inhalation study is available for ammonium nitrate, but as the vapour pressure is considered negligible and the particle size of ammonim nitrate shows no inhalable fraction (0% < 100 µm) it is clear that no study is required according to REACH Annex VIII.
Justification for selection of acute toxicity – oral endpoint
One acute oral key study is available.
Justification for selection of acute toxicity – dermal endpoint
One acute dermal study is available.
Justification for classification or non-classification
Based on the data available, ammonium nitrate does not have to classified for acute toxicity, according to Regulation (EC) No 1272/2008. According to GHS the substance is classified as Category 5 for oral toxicity, however this is not implemented in the EU and therefore not applicable.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
